Tyra Biosciences Ownership | Who Owns Tyra Biosciences?
Tyra Biosciences Ownership Summary
Tyra Biosciences is owned by 112.70% institutional investors, 2.85% insiders. Ra capital management is the largest institutional shareholder, holding 19.76% of TYRA shares. Fidelity OTC is the top mutual fund, with 5.52% of its assets in Tyra Biosciences shares.
TYRA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Tyra Biosciences | 112.70% | 2.85% | -15.55% |
| Sector | Healthcare Stocks | 50.51% | 12.37% | 37.12% |
| Industry | Biotech Stocks | 48.95% | 12.07% | 38.98% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 12.20M | 19.76% | $389.62M |
| Fmr | 8.92M | 14.45% | $284.92M |
| Boxer capital | 6.45M | 12.35% | $103.11M |
| Nextech invest | 4.06M | 6.89% | $56.38M |
| Janus henderson group | 3.89M | 6.53% | $148.87M |
| Alta partners management | 3.82M | 6.19% | $122.12M |
| Nextech invest | 3.55M | 5.76% | $113.50M |
| Tcg crossover management | 3.25M | 5.26% | $103.77M |
| Blackrock funding, inc. /de | 3.03M | 4.91% | $96.84M |
| Price t rowe associates inc /md/ | 2.78M | 4.51% | $88.88M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Alta partners management | 3.82M | 95.92% | $122.12M |
| Canaan partners xi | 750.00K | 18.82% | $23.95M |
| 5am venture management | 1.03M | 11.42% | $32.88M |
| Nextech invest | 4.06M | 9.15% | $56.38M |
| Boxer capital | 6.45M | 5.43% | $103.11M |
| Nextech invest | 3.55M | 5.39% | $113.50M |
| Sio capital management | 695.32K | 3.68% | $22.21M |
| Commodore capital lp | 1.88M | 3.57% | $59.89M |
| Stempoint capital lp | 632.75K | 3.48% | $20.21M |
| Ra capital management | 12.20M | 3.39% | $389.62M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Price t rowe associates inc /md/ | 2.78M | 0.01% | 1.80M |
| Fmr | 8.92M | 0.01% | 1.17M |
| Hood river capital management | 1.02M | 0.24% | 1.02M |
| Janus henderson group | 3.89M | 0.07% | 955.15K |
| State street | 2.14M | 0.00% | 924.29K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Farallon capital management | - | - | -3.58M |
| Kynam capital management, lp | - | - | -1.56M |
| Fairmount funds management | - | - | -1.39M |
| Logos global management lp | - | - | -850.00K |
| Point72 asset management | 38.85K | 0.00% | -835.34K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Hood river capital management | 1.02M | 0.24% | 1.02M | $32.48M |
| Siren | 725.00K | 0.47% | 725.00K | $23.16M |
| Sixth street partners management company | 267.70K | 0.00% | 267.70K | $8.55M |
| Qube research | 266.93K | 0.01% | 266.93K | $8.53M |
| Adage capital partners gp | 162.00K | 0.01% | 162.00K | $5.17M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -2.00 |
| Ifp advisors | -2.00 |
| Mai capital management | -4.00 |
| Capital performance advisors llp | -5.00 |
| Twin peaks wealth advisors | -7.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 176 | 2.33% | 69,590,262 | 5.54% | 112 | 0.92% | 110 | 5.77% | 43 | 19.44% |
| Mar 31, 2026 | 56 | -57.89% | 7,550,823 | -86.71% | 12 | 0.14% | 36 | -50.00% | 9 | -76.92% |
| Dec 31, 2025 | 93 | -19.83% | 26,357,561 | -52.63% | 44 | 0.51% | 49 | - | 28 | -26.32% |
| Sep 30, 2025 | 115 | -4.17% | 55,638,535 | -1.68% | 93 | 1.03% | 49 | -40.24% | 38 | 90.00% |
| Jun 30, 2025 | 119 | 1.71% | 56,577,138 | 16.52% | 95 | 1.42% | 80 | 25.00% | 21 | -32.26% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity OTC | 3.29M | 5.52% | 15.68K |
| State Street® SPDR® S&P® Biotech ETF | 1.37M | 2.30% | 3.15K |
| Vanguard Total Stock Mkt Idx Inv | 1.14M | 1.91% | 299.30K |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.14M | 1.91% | 299.30K |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.14M | 1.90% | - |
| iShares Russell 2000 ETF | 931.66K | 1.56% | -16.51K |
| US Small-Cap Growth II Equity Comp | 793.14K | 1.33% | 571.66K |
| T. Rowe Price New Horizons | 793.14K | 1.33% | 401.60K |
| Fidelity Advisor Equity Growth I | 678.60K | 1.14% | - |
| Janus Henderson Hrzn Biotec E2 USD | 652.67K | 1.10% | 132.47K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 25, 2026 | KAPLAN GILLA | - | Sell | $528.51K |
| Feb 12, 2026 | Bensen Daniel | Chief Discovery Officer | Sell | $195.93K |
| Feb 12, 2026 | Bensen Daniel | Chief Discovery Officer | Sell | $67.04K |
| Jan 12, 2026 | Bensen Daniel | Chief Discovery Officer | Sell | $198.61K |
| Jan 12, 2026 | Bensen Daniel | Chief Discovery Officer | Sell | $29.58K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | - | 5 |
| 2025 Q4 | - | 9 |
| 2025 Q3 | - | - |
| 2025 Q2 | 6 | 5 |
TYRA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools